| 1 |
Patel P, Rai V, Agrawal DK. Role of oncostatin-M in ECM remodeling and plaque vulnerability. Mol Cell Biochem 2023. [PMID: 36856919 DOI: 10.1007/s11010-023-04673-8] [Reference Citation Analysis]
|
| 2 |
Zaidi SAH, Lemtalsi T, Xu Z, Santana I, Sandow P, Labazi L, Caldwell RW, Caldwell RB, Rojas MA. Role of acyl-coenzyme A: cholesterol transferase 1 (ACAT1) in retinal neovascularization. J Neuroinflammation 2023;20:14. [PMID: 36691048 DOI: 10.1186/s12974-023-02700-5] [Reference Citation Analysis]
|
| 3 |
Xu T, Wang C, Chen X, Bai J, Wang E, Sun M. Coexpression of c-Jun in multiple-chain DAP-CAR-engineered T-cells for solid tumor therapy. Immunotherapy 2022;14:1457-66. [PMID: 36597720 DOI: 10.2217/imt-2022-0171] [Reference Citation Analysis]
|
| 4 |
Matos ADO, Dantas PHDS, Queiroz HAGDB, Silva-sales M, Sales-campos H. TREM-2: friend or foe in infectious diseases? Critical Reviews in Microbiology 2022. [DOI: 10.1080/1040841x.2022.2146481] [Reference Citation Analysis]
|
| 5 |
Panagopoulos A, Samant S, Bakhos JJ, Liu M, Khan B, Makadia J, Muhammad F, Kievit FM, Agrawal DK, Chatzizisis YS. Triggering receptor expressed on myeloid cells-1 (TREM-1) inhibition in atherosclerosis. Pharmacology & Therapeutics 2022;238:108182. [DOI: 10.1016/j.pharmthera.2022.108182] [Reference Citation Analysis]
|
| 6 |
Filippova N, Grimes JM, Leavenworth JW, Namkoong D, Yang X, King PH, Crowley M, Crossman DK, Nabors LB. Targeting the TREM1-positive myeloid microenvironment in glioblastoma. Neurooncol Adv 2022;4:vdac149. [PMID: 36249290 DOI: 10.1093/noajnl/vdac149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Zaidi S, Lemtalsi T, Xu Z, Santana I, Sandow P, Labazi L, Caldwell RW, Caldwell RB, Rojas MA. Role of acyl-coenzyme A: cholesterol transferase 1 (ACAT1) during retinal neovascularization in ischemic retinopathies.. [DOI: 10.21203/rs.3.rs-1972381/v1] [Reference Citation Analysis]
|
| 8 |
Siskind S, Brenner M, Wang P. TREM-1 Modulation Strategies for Sepsis. Front Immunol 2022;13:907387. [DOI: 10.3389/fimmu.2022.907387] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Zhang Z, Luqman A, Zhang Q, Liu W. Progress of Folic Acid-Folate Receptor as Drug Carriers in Targeted Drug Delivery System. SHS Web Conf 2022;144:01002. [DOI: 10.1051/shsconf/202214401002] [Reference Citation Analysis]
|
| 10 |
Wang Y, Chu Y, Cao F, Chen Z, Xu H, Wang S, Ma J. The emerging role of triggering receptor expressed on myeloid cell-2 in malignant tumor. Cent Eur J Immunol 2022;47:373-81. [PMID: 36817396 DOI: 10.5114/ceji.2022.124387] [Reference Citation Analysis]
|
| 11 |
Xie Z, Li X, He Y, Wu S, Wang S, Sun J, He Y, Lun Y, Xin S, Zhang J. Analysis of the Prognostic Value and Potential Molecular Mechanisms of TREM-1 Overexpression in Papillary Thyroid Cancer via Bioinformatics Methods. Front Endocrinol (Lausanne) 2021;12:646793. [PMID: 34122331 DOI: 10.3389/fendo.2021.646793] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
